As diabetes continues to affect millions across Europe, the region’s healthcare sector is rapidly shifting towards solutions that improve disease management and patient outcomes. Among the most ...
Global 3D Cell Culture Market OverviewThe global 3D cell culture market is poised for significant expansion, with projections ...
The global hearing aids market is projected to grow at a rate of 6–7% over the next five years. This growth is driven by ...
The global obesity drugs market is projected to grow at a robust compound annual growth rate (CAGR) of approximately 25% ...
Creative Biogene, a frontrunner in biotechnology solutions, providing cost-effective consumables and reagents, focusing on first generation as well as next-generation sequencing and DNA fragment ...
GOTHENBURG, SE / ACCESS Newswire / April 30, 2026 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments ...
Grants support discovery and development of novel drug candidates and evaluation and prioritization of advanced drug regimens for clinical testingNew funding from the Gates Foundation extends Evotec's ...
An Evidence-Based Supplement Formulated to Improve Testosterone Levels* ROCKVILLE, MD / ACCESS Newswire / April 30, 2026 / Theralogix, a trusted leader in nutritional supplements, is proud to announce ...
SOLANA BEACH, CA / ACCESS Newswire / April 29, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the ...
Largest shareholder pledges entire equity stake as collateral for milestone obligations, reinforcing alignment with public shareholders BELLEVUE, WA / ACCESS Newswire / April 29, 2026 / OSR Holdings, ...
GOTHENBURG, SE / ACCESS Newswire / April 29, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, announced today that ...
First-in-Class enVVe system to be evaluated in TAVVE U.S. Pivotal TrialClinical site activation and patient enrollment expected to commence later this yearLarge unmet clinical need for approximately 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results